DUSP6 and ovarian carcinoma: Since SP cells are predominantly G1 cell cycle phase arrested51, and chemotherapy-resistant, we hypothesized that DUSP6 may increase the G0/G1 phase ratio in ovarian cancer cells by negatively regulating the ERK signaling pathway, which then may lead to cellular quiescence and therefore chemotherapy-resistance.